Specifically, we observed a significant increase in NKG2D expression in the NK cells from CLL patients when their PBMCs were cultured with scFvB1IL15 or IL15 compared to the non-stimulated condition. This evidence concerns the gene KLRK1 and B-cell chronic lymphocytic leukemia.